Filing Flows › Aspira Women's Health (AWHL) › Q2 2026 › vs Q1 2026
Aspira Women's Health (AWHL) Q2 2026 vs Q1 2026 (quarter over quarter)
Aspira Women's Health's revenue rose $79K (+4%) from $2.0M in Q1 2026 to $2.0M in Q2 2026.
Aspira Women's Health, Q2 2026: revenue $2.0M (-15% year over year), operating margin -89.7%, net loss $2.4M, operating cash flow −$2.0M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $2.0M | $2.0M | $79K | +4% |
| Net loss | $2.4M | −$676K | $3.1M | — |
| Costs & expenses | $4.5M | $4.8M | −$380K | -8% |
| Operating costs | $3.9M | $4.2M | −$289K | -7% |
| Interest & other, net | $585K | −$2.9M | $3.5M | — |
| Cost of revenue | $915K | $896K | $19K | +2% |
| Research & development | $692K | $1.2M | −$534K | -44% |
| Sales & marketing | $567K | $543K | $24K | +4% |
| General & admin | $1.7M | $1.5M | $202K | +13% |
| Operating cash sources | $2.4M | −$676K | $3.1M | — |
| Depreciation & amortization | $40K | $40K | $0 | 0% |
| Share-based compensation | $19K | $42K | −$23K | -55% |
| Working capital & other | $351K | −$1.1M | $1.5M | — |
| Cash used in operations | $2.0M | $359K | $1.7M | +460% |
| Net loss absorbed | $2.4M | −$676K | $3.1M | — |
Questions
How much did Aspira Women's Health's revenue grow quarter over quarter in Q2 2026?
Aspira Women's Health's revenue rose $79K (+4%) from $2.0M in Q1 2026 to $2.0M in Q2 2026.